Erratum: Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma (Cancer Cell (2016) 29(5) (723–736) (S153561081630160X) (10.1016/j.ccell.2016.04.002));Comprehensive pan-genomic characterization of adrenocortical carcinoma

Cancer Cell

Volumn 29, Issue 5, 2016, Pages 723-736

  Zheng, Siyuan ^a   Cherniack, Andrew D ^b,c   Dewal, Ninad ^d   Moffitt, Richard A ^e   Danilova, Ludmila ^f   Murray, Bradley A ^b,c,ae   Lerario, Antonio M ^g,h,i   Else, Tobias ^h,i   Knijnenburg, Theo A ^j   Ciriello, Giovanni ^k,l   Kim, Seungchan ^m   Assie, Guillaume ^n,o,p,q   Morozova, Olena ^r   Akbani, Rehan ^a   Shih, Juliann ^b,c   Hoadley, Katherine A ^e   Choueiri, Toni K ^c,s   Waldmann, Jens ^q,t   Mete, Ozgur ^u   Robertson, A Gordon ^v   Wu, Hsin Ta ^w   Raphael, Benjamin J ^w   Shao, Lina ^h   Meyerson, Matthew ^b,c   Demeure, Michael J ^m,af   Beuschlein, Felix ^q,x   Gill, Anthony J ^y,z   Sidhu, Stan B ^y,z   Almeida, Madson Q ^g   Fragoso, Maria C B V ^g   Cope, Leslie M ^f   Kebebew, Electron ^aa   Habra, Mouhammed A ^a   Whitsett, Timothy G ^m   Bussey, Kimberly J ^m,ab   Rainey, William E ^h,i   Asa, Sylvia L ^u   Bertherat, Jérôme ^n,o,p,q   Fassnacht, Martin ^q,ac,ad   Wheeler, David A ^d   Hammer, Gary D ^h,i   Giordano, Thomas J ^h,i   Verhaak, Roel G W ^a   Benz, Christopher ^ag   Ally, Adrian ^ag   Balasundaram, Miruna ^ag   Bowlby, Reanne ^ag   Brooks, Denise ^ag   Butterfield, Yaron S N ^ag   Carlsen, Rebecca ^ag   Dhalla, Noreen ^ag   Guin, Ranabir ^ag   Holt, Robert A ^ag   Jones, Steven J M ^ag   Kasaian, Katayoon ^ag   Lee, Darlene ^ag   Li, Haiyan I ^ag   Lim, Lynette ^ag   Ma, Yussanne ^ag   Marra, Marco A ^ag   Mayo, Michael ^ag   Moore, Richard A ^ag   Mungall, Andrew J ^ag   Mungall, Karen ^ag   Sadeghi, Sara ^ag   Schein, Jacqueline E ^ag   Sipahimalani, Payal ^ag   Tam, Angela ^ag   Thiessen, Nina ^ag   Park, Peter J ^ag   Kroiss, Matthias ^ag   Gao, Jianjiong ^ag   Sander, Chris ^ag   Schultz, Nikolaus ^ag   Jones, Corbin D ^ag   Kucherlapati, Raju ^ag   Mieczkowski, Piotr A ^ag   Parker, Joel S ^ag   Perou, Charles M ^ag   Tan, Donghui ^ag   Veluvolu, Umadevi ^ag   Wilkerson, Matthew D ^ag   Hayes, D Neil ^ag   Ladanyi, Marc ^ag   Quinkler, Marcus ^ag   Auman, J Todd ^ag   Latronico, Ana Claudia ^ag   Mendonca, Berenice B ^ag   Sibony, Mathilde ^ag   Sanborn, Zack ^ag   Bellair, Michelle ^ag   Buhay, Christian ^ag   Covington, Kyle ^ag   Dahdouli, Mahmoud ^ag   Dinh, Huyen ^ag   Doddapaneni, Harsha ^ag   Downs, Brittany ^ag   Drummond, Jennifer ^ag   Gibbs, Richard ^ag   Hale, Walker ^ag   Han, Yi ^ag   Hawes, Alicia ^ag   Hu, Jianhong ^ag   Kakkar, Nipun ^ag   Kalra, Divya ^ag   Khan, Ziad ^ag   Kovar, Christine ^ag   Lee, Sandy ^ag   Lewis, Lora ^ag   Morgan, Margaret ^ag   Morton, Donna ^ag   Muzny, Donna ^ag   Santibanez, Jireh ^ag   Xi, Liu ^ag   Dousset, Bertrand ^ag   Groussin, Lionel ^ag   Libé, Rossella ^ag   Chin, Lynda ^ag   Reynolds, Sheila ^ag   Shmulevich, Ilya ^ag   Chudamani, Sudha ^ag   Liu, Jia ^ag   Lolla, Laxmi ^ag   Wu, Ye ^ag   Yeh, Jen Jen ^ag   Balu, Saianand ^ag   Bodenheimer, Tom ^ag   Hoyle, Alan P ^ag   Jefferys, Stuart R ^ag   Meng, Shaowu ^ag   Mose, Lisle E ^ag   Shi, Yan ^ag   Simons, Janae V ^ag   Soloway, Matthew G ^ag   Wu, Junyuan ^ag   Zhang, Wei ^ag   Shaw, Kenna R Mills ^ag   Demchok, John A ^ag   Felau, Ina ^ag   Sheth, Margi ^ag   Tarnuzzer, Roy ^ag   Wang, Zhining ^ag   Yang, Liming ^ag   Zenklusen, Jean C ^ag   Zhang, Jiashan ^ag   Davidsen, Tanja ^ag   Crawford, Catherine ^ag   Hutter, Carolyn M ^ag   Sofia, Heidi J ^ag   Roach, Jeffrey ^ag   Bshara, Wiam ^ag   Gaudioso, Carmelo ^ag   Morrison, Carl ^ag   Soon, Patsy ^ag   Alonso, Shelley ^ag   Baboud, Julien ^ag   Pihl, Todd ^ag   Raman, Rohini ^ag   Sun, Qiang ^ag   Wan, Yunhu ^ag   Naresh, Rashi ^ag   Arachchi, Harindra ^ag   Beroukhim, Rameen ^ag   Carter, Scott L ^ag   Cho, Juok ^ag   Frazer, Scott ^ag   Gabriel, Stacey B ^ag   Getz, Gad ^ag   Heiman, David I ^ag   Kim, Jaegil ^ag   Lawrence, Michael S ^ag   Lin, Pei ^ag   Noble, Michael S ^ag   Saksena, Gordon ^ag   Schumacher, Steven E ^ag   Sougnez, Carrie ^ag   Voet, Doug ^ag   Zhang, Hailei ^ag   Bowen, Jay ^ag   Coppens, Sara ^ag   Gastier Foster, Julie M ^ag   Gerken, Mark ^ag   Helsel, Carmen ^ag   Leraas, Kristen M ^ag   Lichtenberg, Tara M ^ag   Ramirez, Nilsa C ^ag   Wise, Lisa ^ag   Zmuda, Erik ^ag   Baylin, Stephen ^ag   Herman, James G ^ag   LoBello, Janine ^ag   Watanabe, Aprill ^ag   Haussler, David ^ag   Radenbaugh, Amie ^ag   Rao, Arjun ^ag   Zhu, Jingchun ^ag   Bartsch, Detlef K ^ag   Sbiera, Silviu ^ag   Allolio, Bruno ^ag   Deutschbein, Timo ^ag   Ronchi, Cristina ^ag   Raymond, Victoria M ^ag   Vinco, Michelle ^ag   Amble, Linda ^ag   Bootwalla, Moiz S ^ag   Lai, Phillip H ^ag   Van Den Berg, David J ^ag   Weisenberger, Daniel J ^ag   Robinson, Bruce ^ag   Ju, Zhenlin ^ag   Kim, Hoon ^ag   Ling, Shiyun ^ag   Liu, Wenbin ^ag   Lu, Yiling ^ag   Mills, Gordon B ^ag   Sircar, Kanishka ^ag   Wang, Qianghu ^ag   Yoshihara, Kosuke ^ag   Laird, Peter W ^ag   Fan, Yu ^ag   Wang, Wenyi ^ag   Shinbrot, Eve ^ag   Reincke, Martin ^ag   Weinstein, John N ^ag   Meier, Sam ^ag   Defreitas, Timothy ^ag   more..

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF NORTH CAROLINA   (United States)

^f JOHNS HOPKINS UNIVERSITY   (United States)

^g UNIVERSITY OF SÃO PAULO   (Brazil)

^h UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

ⁱ UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

^j INSTITUTE FOR SYSTEMS BIOLOGY   (United States)

^k UNIVERSITY OF LAUSANNE   (Switzerland)

^l MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^m TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

ⁿ INSTITUT COCHIN   (France)

^o UNIVERSITÉ PARIS DESCARTES   (France)

^p European Network for the Study of Adrenal Tumors ^*  (France)

^q European Network for the Study of Adrenal Tumors   (France)

^r University of California Santa Cruz   (United States)

^s BRIGHAM AND WOMEN S HOSPITAL   (United States)

^t UNIVERSITY HOSPITAL MARBURG   (Germany)

^u UNIVERSITY HEALTH NETWORK   (Canada)

^v BRITISH COLUMBIA CANCER AGENCY   (Canada)

^w Brown Univerity   (United States)

^x LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^y UNIVERSITY OF SYDNEY   (Australia)

^z ROYAL NORTH SHORE HOSPITAL   (Australia)

^aa NATIONAL CANCER INSTITUTE   (United States)

^ab ARIZONA STATE UNIVERSITY   (United States)

^ac UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^ad UNIVERSITY OF WÜRZBURG   (Germany)

^ae INTELLIA THERAPEUTICS   (United States)

^af Ashion Analytics   (United States)

^ag NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

MOLECULAR MARKER; TELOMERASE REVERSE TRANSCRIPTASE; TELOMERIC REPEAT BINDING FACTOR 2;

ADRENAL CORTEX CARCINOMA; ADULT; ARTICLE; CCNE1 GENE; DNA METHYLATION; DNA PROBE; FEMALE; GENE DOSAGE; GENE EXPRESSION; GENOME; HUMAN; HUMAN TISSUE; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PRKAR1A GENE; RPL22 GENE; TELOMERE; TUMOR GENE; WHOLE GENOME DOUBLING; ADOLESCENT; ADRENAL CORTEX NEOPLASMS; ADRENOCORTICAL CARCINOMA; AGED; CHILD; CLINICAL TRIAL; DISEASE FREE SURVIVAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION; GENETICS; GENOMICS; HUMAN GENOME; MIDDLE AGED; MULTICENTER STUDY; MUTATION; PATHOLOGY; PROCEDURES; PROGNOSIS; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADRENAL CORTEX NEOPLASMS; ADRENOCORTICAL CARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CHILD; DISEASE-FREE SURVIVAL; DNA METHYLATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; GENOMICS; HUMANS; MALE; MIDDLE AGED; MUTATION; OUTCOME ASSESSMENT (HEALTH CARE); PROGNOSIS; YOUNG ADULT;

EID: 84975223445     PISSN: 15356108     EISSN: 18783686     Source Type: Journal    
DOI: 10.1016/j.ccell.2016.07.013     Document Type: Erratum

References (58)

1. Alexandrov L.B., Nik-Zainal S., Wedge D.C., Aparicio S.A., Behjati S., Biankin A.V., Bignell G.R., Bolli N., Borg A., Borresen-Dale A.L., et al. Signatures of mutational processes in human cancer. Nature 2013, 500:415-421.
2. Anselmo J., Medeiros S., Carneiro V., Greene E., Levy I., Nesterova M., Lyssikatos C., Horvath A., Carney J.A., Stratakis C.A. A large family with Carney complex caused by the S147G PRKAR1A mutation shows a unique spectrum of disease including adrenocortical cancer. J. Clin. Endocrinol. Metab. 2012, 97:351-359.
3. Assie G., Letouze E., Fassnacht M., Jouinot A., Luscap W., Barreau O., Omeiri H., Rodriguez S., Perlemoine K., Rene-Corail F., et al. Integrated genomic characterization of adrenocortical carcinoma. Nat. Genet. 2014, 46:607-612.
4. Bertherat J., Groussin L., Sandrini F., Matyakhina L., Bei T., Stergiopoulos S., Papageorgiou T., Bourdeau I., Kirschner L.S., Vincent-Dejean C., et al. Molecular and functional analysis of PRKAR1A and its locus (17q22-24) in sporadic adrenocortical tumors: 17q losses, somatic mutations, and protein kinase A expression and activity. Cancer Res. 2003, 63:5308-5319.
5. Beuschlein F., Fassnacht M., Assie G., Calebiro D., Stratakis C.A., Osswald A., Ronchi C.L., Wieland T., Sbiera S., Faucz F.R., et al. Constitutive activation of PKA catalytic subunit in adrenal Cushing's syndrome. N. Engl. J. Med. 2014, 370:1019-1028.
6. Bilimoria K.Y., Shen W.T., Elaraj D., Bentrem D.J., Winchester D.J., Kebebew E., Sturgeon C. Adrenocortical carcinoma in the United States: treatment utilization and prognostic factors. Cancer 2008, 113:3130-3136.
7. Blasco M.A. Telomeres and human disease: ageing, cancer and beyond. Nat. Rev. Genet. 2005, 6:611-622.
8. Calebiro D., Hannawacker A., Lyga S., Bathon K., Zabel U., Ronchi C., Beuschlein F., Reincke M., Lorenz K., Allolio B., et al. PKA catalytic subunit mutations in adrenocortical Cushing's adenoma impair association with the regulatory subunit. Nat. Commun. 2014, 5:5680.
9. Carter S.L., Cibulskis K., Helman E., McKenna A., Shen H., Zack T., Laird P.W., Onofrio R.C., Winckler W., Weir B.A., et al. Absolute quantification of somatic DNA alterations in human cancer. Nat. Biotechnol. 2012, 30:413-421.
10. Chan B.C., Li Q., Chow S.K., Ching A.K., Liew C.T., Lim P.L., Lee K.K., Chan J.Y., Chui Y.L. BRE enhances in vivo growth of tumor cells. Biochem. Biophys. Res. Commun. 2005, 326:268-273.
11. Chu J., Sadeghi S., Raymond A., Jackman S.D., Nip K.M., Mar R., Mohamadi H., Butterfield Y.S., Robertson A.G., Birol I. BioBloom tools: fast, accurate and memory-efficient host species sequence screening using bloom filters. Bioinformatics 2014, 30:3402-3404.
12. Ciriello G., Miller M.L., Aksoy B.A., Senbabaoglu Y., Schultz N., Sander C. Emerging landscape of oncogenic signatures across human cancers. Nat. Genet. 2013, 45:1127-1133.
13. Davoli T., de Lange T. Telomere-driven tetraploidization occurs in human cells undergoing crisis and promotes transformation of mouse cells. Cancer Cell 2012, 21:765-776.
14. de Reynies A., Assie G., Rickman D.S., Tissier F., Groussin L., Rene-Corail F., Dousset B., Bertagna X., Clauser E., Bertherat J. Gene expression profiling reveals a new classification of adrenocortical tumors and identifies molecular predictors of malignancy and survival. J. Clin. Oncol. 2009, 27:1108-1115.
15. de Ruijter T.C., de Hoon J.P., Slaats J., de Vries B., Janssen M.J., van Wezel T., Aarts M.J., van Engeland M., Tjan-Heijnen V.C., Van Neste L., Veeck J. Formalin-fixed, paraffin-embedded (FFPE) tissue epigenomics using Infinium HumanMethylation450 BeadChip assays. Lab. Invest. 2015, 95:833-842.
16. Ding Z., Mangino M., Aviv A., Spector T., Durbin R. Estimating telomere length from whole genome sequence data. Nucleic Acids Res. 2014, 42:e75. Consortium, U. K.
17. Else T., Giordano T.J., Hammer G.D. Evaluation of telomere length maintenance mechanisms in adrenocortical carcinoma. J. Clin. Endocrinol. Metab. 2008, 93:1442-1449.
18. Else T., Kim A.C., Sabolch A., Raymond V.M., Kandathil A., Caoili E.M., Jolly S., Miller B.S., Giordano T.J., Hammer G.D. Adrenocortical carcinoma. Endocr. Rev. 2014, 35:282-326.
19. Else T., Williams A.R., Sabolch A., Jolly S., Miller B.S., Hammer G.D. Adjuvant therapies and patient and tumor characteristics associated with survival of adult patients with adrenocortical carcinoma. J. Clin. Endocrinol. Metab. 2014, 99:455-461.
20. Fassnacht M., Johanssen S., Quinkler M., Bucsky P., Willenberg H.S., Beuschlein F., Terzolo M., Mueller H.H., Hahner S., Allolio B., et al. Limited prognostic value of the 2004 International Union against Cancer staging classification for adrenocortical carcinoma: proposal for a Revised TNM Classification. Cancer 2009, 115:243-250.
21. Fassnacht M., Kroiss M., Allolio B. Update in adrenocortical carcinoma. J. Clin. Endocrinol. Metab. 2013, 98:4551-4564.
22. Futreal P.A., Coin L., Marshall M., Down T., Hubbard T., Wooster R., Rahman N., Stratton M.R. A census of human cancer genes. Nat. Rev. Cancer 2004, 4:177-183.
23. Giordano T.J. The argument for mitotic rate-based grading for the prognostication of adrenocortical carcinoma. Am. J. Surg. Pathol. 2011, 35:471-473.
24. Giordano T.J., Thomas D.G., Kuick R., Lizyness M., Misek D.E., Smith A.L., Sanders D., Aljundi R.T., Gauger P.G., Thompson N.W., et al. Distinct transcriptional profiles of adrenocortical tumors uncovered by DNA microarray analysis. Am. J. Pathol. 2003, 162:521-531.
25. Giordano T.J., Kuick R., Else T., Gauger P.G., Vinco M., Bauersfeld J., Sanders D., Thomas D.G., Doherty G., Hammer G. Molecular classification and prognostication of adrenocortical tumors by transcriptome profiling. Clin. Cancer Res. 2009, 15:668-676.
26. Goh G., Scholl U.I., Healy J.M., Choi M., Prasad M.L., Nelson-Williams C., Kunstman J.W., Korah R., Suttorp A.C., Dietrich D., et al. Recurrent activating mutation in PRKACA in cortisol-producing adrenal tumors. Nat. Genet. 2014, 46:613-617.
27. Gong Y., Zack T.I., Morris L.G., Lin K., Hukkelhoven E., Raheja R., Tan I.L., Turcan S., Veeriah S., Meng S., et al. Pan-cancer genetic analysis identifies PARK2 as a master regulator of G1/S cyclins. Nat. Genet. 2014, 46:588-594.
28. Heaphy C.M., de Wilde R.F., Jiao Y., Klein A.P., Edil B.H., Shi C., Bettegowda C., Rodriguez F.J., Eberhart C.G., Hebbar S., et al. Altered telomeres in tumors with ATRX and DAXX mutations. Science 2011, 333:425.
29. Hsing A.W., Nam J.M., Co Chien H.T., McLaughlin J.K., Fraumeni J.F. Risk factors for adrenal cancer: an exploratory study. Int. J. Cancer 1996, 65:432-436.
30. Huang F.W., Hodis E., Xu M.J., Kryukov G.V., Chin L., Garraway L.A. Highly recurrent TERT promoter mutations in human melanoma. Science 2013, 339:957-959.
31. Juhlin C.C., Goh G., Healy J.M., Fonseca A.L., Scholl U.I., Stenman A., Kunstman J.W., Brown T.C., Overton J.D., Mane S.M., et al. Whole-exome sequencing characterizes the landscape of somatic mutations and copy number alterations in adrenocortical carcinoma. J. Clin. Endocrinol. Metab. 2015, 100:E493-E502.
32. Jung S., Kim S. EDDY: a novel statistical gene set test method to detect differential genetic dependencies. Nucleic Acids Res. 2014, 42:e60.
33. Kirschner L.S., Sandrini F., Monbo J., Lin J.P., Carney J.A., Stratakis C.A. Genetic heterogeneity and spectrum of mutations of the PRKAR1A gene in patients with the carney complex. Hum. Mol. Genet. 2000, 9:3037-3046.
34. Krivtsov A.V., Armstrong S.A. MLL translocations, histone modifications and leukaemia stem-cell development. Nat. Rev. Cancer 2007, 7:823-833.
35. Lawrence M.S., Stojanov P., Polak P., Kryukov G.V., Cibulskis K., Sivachenko A., Carter S.L., Stewart C., Mermel C.H., Roberts S.A., et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature 2013, 499:214-218.
36. Lawrence M.S., Stojanov P., Mermel C.H., Robinson J.T., Garraway L.A., Golub T.R., Meyerson M., Gabriel S.B., Lander E.S., Getz G. Discovery and saturation analysis of cancer genes across 21 tumour types. Nature 2014, 505:495-501.
37. Leiserson M.D., Vandin F., Wu H.T., Dobson J.R., Eldridge J.V., Thomas J.L., Papoutsaki A., Kim Y., Niu B., McLellan M., et al. Pan-cancer network analysis identifies combinations of rare somatic mutations across pathways and protein complexes. Nat. Genet. 2015, 47:106-114.
38. Letouze E., Rosati R., Komechen H., Doghman M., Marisa L., Fluck C., de Krijger R.R., van Noesel M.M., Mas J.C., Pianovski M.A., et al. SNP array profiling of childhood adrenocortical tumors reveals distinct pathways of tumorigenesis and highlights candidate driver genes. J. Clin. Endocrinol. Metab. 2012, 97:E1284-E1293.
39. Liu T.T., Brown T.C., Juhlin C.C., Andreasson A., Wang N., Backdahl M., Healy J.M., Prasad M.L., Korah R., Carling T., et al. The activating TERT promoter mutation C228T is recurrent in subsets of adrenal tumors. Endocr. Relat. Cancer 2014, 21:427-434.
40. Maser R.S., DePinho R.A. Connecting chromosomes, crisis, and cancer. Science 2002, 297:565-569.
41. McPherson A., Hormozdiari F., Zayed A., Giuliany R., Ha G., Sun M.G., Griffith M., Heravi Moussavi A., Senz J., Melnyk N., et al. deFuse: an algorithm for gene fusion discovery in tumor RNA-Seq data. PLoS Comput. Biol. 2011, 7:e1001138.
42. Mermel C.H., Schumacher S.E., Hill B., Meyerson M.L., Beroukhim R., Getz G. GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol. 2011, 12:R41.
43. Miao J., Panesar N.S., Chan K.T., Lai F.M., Xia N., Wang Y., Johnson P.J., Chan J.Y. Differential expression of a stress-modulating gene, BRE, in the adrenal gland, in adrenal neoplasia, and in abnormal adrenal tissues. J. Histochem. Cytochem. 2001, 49:491-500.
44. Miller B.S., Gauger P.G., Hammer G.D., Giordano T.J., Doherty G.M. Proposal for modification of the ENSAT staging system for adrenocortical carcinoma using tumor grade. Langenbecks Arch. Surg. 2010, 395:955-961.
45. Palacios R., Sugawara I. Hydrocortisone abrogates proliferation of T cells in autologous mixed lymphocyte reaction by rendering the interleukin-2 Producer T cells unresponsive to interleukin-1 and unable to synthesize the T-cell growth factor. Scand. J. Immunol. 1982, 15:25-31.
46. Pinto E.M., Chen X., Easton J., Finkelstein D., Liu Z., Pounds S., Rodriguez-Galindo C., Lund T.C., Mardis E.R., Wilson R.K., et al. Genomic landscape of paediatric adrenocortical tumours. Nat. Commun. 2015, 6:6302.
47. Raymond V.M., Everett J.N., Furtado L.V., Gustafson S.L., Jungbluth C.R., Gruber S.B., Hammer G.D., Stoffel E.M., Greenson J.K., Giordano T.J., Else T. Adrenocortical carcinoma is a lynch syndrome-associated cancer. J. Clin. Oncol. 2013, 31:3012-3018.
48. Rozek L.S., Rennert G., Gruber S.B. APC E1317Q is not associated with Colorectal Cancer in a population-based case-control study in Northern Israel. Cancer Epidemiol. Biomarkers Prev. 2006, 15:2325-2327.
49. Stewart S.A., Weinberg R.A. Telomeres: cancer to human aging. Annu. Rev. Cell Dev. Biol. 2006, 22:531-557.
50. Thirlwell C., Eymard M., Feber A., Teschendorff A., Pearce K., Lechner M., Widschwendter M., Beck S. Genome-wide DNA methylation analysis of archival formalin-fixed paraffin-embedded tissue using the Illumina Infinium HumanMethylation27 BeadChip. Methods 2010, 52:248-254.
51. Tissier F., Cavard C., Groussin L., Perlemoine K., Fumey G., Hagnere A.M., Rene-Corail F., Jullian E., Gicquel C., Bertagna X., et al. Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors. Cancer Res. 2005, 65:7622-7627.
52. Torres-Garcia W., Zheng S., Sivachenko A., Vegesna R., Wang Q., Yao R., Berger M.F., Weinstein J.N., Getz G., Verhaak R.G. PRADA: pipeline for RNA sequencing data analysis. Bioinformatics 2014, 30:2224-2226.
53. Van Allen E.M., Wagle N., Stojanov P., Perrin D.L., Cibulskis K., Marlow S., Jane-Valbuena J., Friedrich D.C., Kryukov G., Carter S.L., et al. Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine. Nat. Med. 2014, 20:682-688.
54. Weiss L.M., Medeiros L.J., Vickery A.L. Pathologic features of prognostic significance in adrenocortical carcinoma. Am. J. Surg. Pathol. 1989, 13:202-206.
55. Yoshihara K., Shahmoradgoli M., Martinez E., Vegesna R., Kim H., Torres-Garcia W., Trevino V., Shen H., Laird P.W., Levine D.A., et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat. Commun. 2013, 4:2612.
56. Yoshihara K., Wang Q., Torres-Garcia W., Zheng S., Vegesna R., Kim H., Verhaak R.G. The landscape and therapeutic relevance of cancer-associated transcript fusions. Oncogene 2015, 34:4845-4854.
57. Zack T.I., Schumacher S.E., Carter S.L., Cherniack A.D., Saksena G., Tabak B., Lawrence M.S., Zhang C.Z., Wala J., Mermel C.H., et al. Pan-cancer patterns of somatic copy number alteration. Nat. Genet. 2013, 45:1134-1140.
58. Zhang Y., Lu H. Signaling to p53: ribosomal proteins find their way. Cancer Cell 2009, 16:369-377.